Profile for United States of America Patent: 2011060041
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for United States of America Patent: 2011060041
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Feb 18, 2024 | Keryx Biopharms | AURYXIA | ferric citrate |
⤷ Sign Up | Apr 21, 2026 | Keryx Biopharms | AURYXIA | ferric citrate |
⤷ Sign Up | Feb 18, 2024 | Keryx Biopharms | AURYXIA | ferric citrate |
⤷ Sign Up | Feb 18, 2024 | Keryx Biopharms | AURYXIA | ferric citrate |
⤷ Sign Up | Feb 18, 2024 | Keryx Biopharms | AURYXIA | ferric citrate |
⤷ Sign Up | Feb 18, 2024 | Keryx Biopharms | AURYXIA | ferric citrate |
⤷ Sign Up | Feb 18, 2024 | Keryx Biopharms | AURYXIA | ferric citrate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |